Clinical Trial Update: Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy

View source ↗

Summary

The document reports a completed administrative claims analysis of Metanx for diabetic peripheral neuropathy. It provides status details of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Metanx

Snippet

Sponsor: Pamlab, L.L.C. | Conditions: Diabetic Peripheral Neuropathy (DPN) | Status: COMPLETED